Nocera is a biotechnology company focused on developing advanced therapeutic solutions aimed at addressing various medical needs. The company harnesses innovative technologies and scientific research to create novel treatments and drug candidates that target specific diseases and conditions, driving advancements in healthcare. Nocera’s commitment to research and development is central to its mission, as it strives to improve patient outcomes and enhance the overall quality of life through groundbreaking biopharmaceuticals. Read More
NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference Carmel LLP (“SRFC”) reported that in 2025 it advised on over 170 announced transactions, with the total value of these transactions exceeding $14 billion, far surpassing the firm’s strong performance in 2024. The transactions, on behalf of various market participants, such as issuers, underwriters and investors, included initial public offerings, secondary public offerings, registered direct offerings, private placements, mergers, acquisitions and cryptocurrency transactions.
TAIPEI, TW / ACCESS Newswire / December 16, 2025 / Nocera, Inc. (NASDAQ:NCRA) ("Nocera" or the "Company"), an industry-agnostic, acquisition-focused company, today announced that the Company plans to allocate $2 million for the purchase of Bitcoin (BTC) for its corporate treasury over the coming weeks.
TAIPEI, TW / ACCESS Newswire / November 20, 2025 / Nocera, Inc. (NASDAQ:NCRA) ("Nocera" or the "Company"), an industry-agnostic, acquisition-focused company, today announced that it closed on the first tranche of funding in the aggregate principal amount of USD $8,000,000.
TAIPEI, TAIWAN / ACCESS Newswire / November 3, 2025 / Nocera, Inc. (NASDAQ:NCRA) ("Nocera" or the "Company"), a company focused on strategic acquisitions and aquaculture operations, announced today that it has entered into a securities purchase agreement with a U.S.-based institutional investor for the private placement of up to $300 million in senior secured convertible notes (the "Facility").
TAIPEI, TAIWAN / ACCESS Newswire / July 16, 2025 / Nocera, Inc. (NASDAQ:NCRA) ("Nocera" or the "Company"), an industry-agnostic, acquisition-focused company, today announced that it received a notification letter (the "Notification Letter") from the Listing Qualifications Department at The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement").
